Abstract
Guidance for the preparation of medical reports for mental health review tribunals
Highlights
Sir: Wilkie et al's (Psychiatric Bulletin, May 2001, 25, 179-183) study of high dose neuroleptics was timely and informative
It is well known that doses of haloperidol higher than 12 mg do not produce any additional clinical benefits while causing increasing side-effects
The findings of the present study suggest that high dose neuroleptic prescribing is not based on sound pharmacological principles
Summary
MOORES, C. & DIRE, D. (1989) Movement disorders as a manifestation of nonketotic hyperglycaemia. (1989) Movement disorders as a manifestation of nonketotic hyperglycaemia. SAFFERMAN, A., LIEBERMAN, J., KANE, J., et al (1991) Update of the clinical efficacy and side effects of clozapine. Justin Sauer Senior House Officer, Nicola Funnell Specialist Registrar, Adrianne Reveley Consultant Psychiatrist, Maudsley Hospital, London SE5 8AZ
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
